OUR NATURE

OUR ETHICAL GUIDELINES

“Because we were vets before becoming researchers, our first responsibility is the quality of life and the quality of care for the pets we look after, working closely with their own veterinary clinics, in their fight against cancer.”

CLINICAL
RESEARCH

OCR is specialized in the conception
and management of clinical trials of pets
with naturally occurring pathologies for
efficacy assessment of drug candidates &
medical devices for Human and Animal Health.

For further information, please contact us.

contact@oncovet-clinical-research.com
+33 (0)3 20 56 82 93

CONTACT

Parc Eurasanté, Lille Métropole
80 Rue du Docteur Yersin, 59120 Loos
FRANCE

+33 (0)3.20.56.82.93

Contact us by Email

PRESS RELEASES

  • Lille, 6th September 2016

    OCR, the company revolutionising the selection of effective drug candidates for cancer, raises €1.25m from Newfund, NFA and the management team in order to accelerate its growth.

  • Lille, 16th July 2015

    OCR and Pierre Fabre’s Phase I Clinical Pharmacology Study published in prestigious Clinical Cancer Research journal

  • Lille, 02nd April 2015

    OCR and Ecrins Therapeutics initiate €1.9m “Dog to Man” pioneering translational research programme to advance human and vet oncology treatment

  • Lille, 23rd March 2015

    OCR and PRISM announce ground-breaking research collaboration to advance real-time diagnosis using mass spectrometry

  • Lille, 30th January 2015

    OCR strengthens veterinary and R&D expertise to respond to the needs of the pharmaceutical industry

Stay connected to OCR,
subscribe to our Newsletter !